Retraction Watch

Tracking retractions as a window into the scientific process

Archive for the ‘for legal reasons’ Category

Court dismisses lawsuit by XMRV-chronic fatigue syndrome researcher

with one comment

mikovitsA California court has dismissed virologist Judy Mikovits’s lawsuit against fourteen people and two Nevada corporations, in part because she failed to submit necessary documents on time.

Mikovits is the author on a now-retracted Science paper suggesting a link between a virus known as XMRV and chronic fatigue syndrome, which has no known cause. She alleged that she was fired from the Whittemore-Peterson Institute for blowing the whistle on her former colleague’s activities, and that the defendants then colluded to imprison and defame her.

The court dismissed her case last Wednesday. According to the court minutes,

Written by Shannon Palus

February 16th, 2016 at 2:00 pm

Lancet retracts 24-year-old paper by “father of nutritional immunology” after reopening inquiry

with 9 comments

lancetFollowing questions from outside experts, a retraction of a related paper, a university investigation and a court case, The Lancet has decided to retract a 1992 paper by Ranjit Kumar Chandra, the self-proclaimed “father of nutritional immunology.

In a lengthy retraction note included in the January 30 issue, the journal explains that:

the balance of probabilities in our judgment is that the reliability of the 1992 Lancet paper by Chandra can no longer be assured.

Chandra is objecting to the retraction.

This retraction was a long time coming, so sit back and relax as we fill in the backstory. Read the rest of this entry »

Intellectual property issues sink cancer paper in JACS

with one comment

176 spine minimum. full size. Editor: Lingling JEM: Leslie RTP: Michael ReidThe authors of a paper on a mechanism for potential cancer therapies are retracting it after realizing they published some proprietary findings “without permission and agreement from St. Jude Children’s Research Hospital.”

According to the retraction note in Journal of the American Chemical Society, the authors included an X-ray crystal structure and data that were gathered at St. Jude’s and considered the hospital’s intellectual property. On the paper, the last author, Zhengding Su, listed an affiliation at St. Jude and Hubei University of Technology in China, along with Amersino Biodevelop Inc., based in Waterloo, Canada.

Here’s the note for “Efficient Reactivation of p53 in Cancer Cells by a Dual MdmX/Mdm2 Inhibitor:”  Read the rest of this entry »

Lead poisoning article disappears for “legal” — but mysterious — reasons

without comments

OM_ak4A 2014 article in Occupational Medicine has been pulled with no retraction notice. Instead, the text was replaced with eight ominous words:

This article has been removed for legal reasons

Read the rest of this entry »

Drug company lawyer letter results in “utterly tedious” retraction

with 2 comments

Image via Intropen

Image via Intropen

What’s in a name?

Well, if it’s the same name as a treatment with nearly $1 billion in sales per year in the U.S., a retraction.

A “mind numbingly boring one,” that is.

Here’s the Twin Research and Human Genetics notice for “EpiPen: An R Package to Investigate Two-Locus Epistatic Models”: Read the rest of this entry »

Retraction of letter alleging sock puppetry now cites “legal reasons”

with 10 comments

jasistEarlier this month, we brought you the story of a retraction from the Journal of the Association for Information Science and Technology involving rivalry and alleged sock puppetry. The author of the now-retracted letter, physicist Lorenzo Iorio, claimed that another researcher was using fake names to criticize his work on arXiv.At the time, the editor of the journal had told everyone concerned that the letter would be retracted, but the retraction notice hadn’t yet appeared. Now it has.

Here’s the notice: Read the rest of this entry »

Crystal unclear? “Business decision” forces retraction of silicon paper

with one comment

jcgrowthA group of researchers in Tokyo has lost their 2013 article in the Journal of Crystal Growth over commercial interests — which don’t appear to be their own.

We’ll explain.

The article, “Interactions between planar defects in bulk 3C-SiC,” came from a team consisting of a researcher at Keio University and scientists at two companies, HOYA Corporation, an optics firm, and SICOXS Corporation, which makes semiconductor wafers.

According to the abstract: Read the rest of this entry »

Co-author of retracted conspiracy ideation-climate skepticism paper addresses apparent contradictions

with 86 comments

Lewandowsky

Lewandowsky

We — and others — have been scratching our heads about the real reasons for the formal retraction on March 21 of a Frontiers in Psychology paper since the journal issued a statement on the subject on Friday that seemed to contradict the retraction notice and that certainly differed from accounts on some blogs. Today, we learned a few more details about what happened in the year between when the paper was provisionally removed and then formally retracted from a post by Stephan Lewandowsky, one of the co-authors of the paper.

The March 21 statement, writes Lewandowsky, Read the rest of this entry »

Controversial paper linking conspiracy ideation to climate change skepticism formally retracted

with 106 comments

frontiersA year after being clumsily removed from the web following complaints, a controversial paper about “the possible role of conspiracist ideation in the rejection of science” is being retracted.

The paper, “Recursive fury: Conspiracist ideation in the blogosphere in response to research on conspiracist ideation,” was authored by Stephan Lewandowsky, John Cook, Klaus Oberauer, and Michael Marriott, and published in Frontiers in Psychology: Personality Science and Individual Differences.

Read the rest of this entry »

Written by Ivan Oransky

March 21st, 2014 at 7:54 am

Paper by Bristol-Myers Squibb researchers retracted for “unsolved legal reasons”

with 3 comments

applied micro biotechA group of researchers at Bristol-Myers Squibb has had a paper retracted for reasons we can’t quite figure out.

All the notice for “Simultaneous expression of antibody light and heavy chains in Pichia pastoris: improving retransformation outcome by linearizing vector at a different site,” published in Applied Microbiology and Biotechnology, says is: Read the rest of this entry »